Repository logo
 
Publication

Is serotonin receptor HTR1B implicated in mesial temporal lobe epilepsy development?

dc.contributor.authorLeal, B.
dc.contributor.authorBarreira, A.
dc.contributor.authorChaves, J.
dc.contributor.authorCarvalho, C.
dc.contributor.authorBettencourt, A.
dc.contributor.authorMartins da Silva, A.
dc.contributor.authorCosta, P.P.
dc.contributor.authorMartins da Silva, B.
dc.date.accessioned2014-04-03T10:35:05Z
dc.date.available2014-04-03T10:35:05Z
dc.date.issued2013-09-22
dc.description.abstractBackground: Evidences from animal models have demonstrated that depletion of brain serotonin (5-HT), a neurotransmitter with a pivotal role in neurodevelopment and brain plasticity, lowers the threshold to induced seizures. It was also demonstrated that anti-epileptic drugs increase endogenous 5-HT concentrations and that 5HT-1B receptors could have an anticonvulsant role. Association studies have demonstrated that a polymorphism (rs6296) in 5HTR-1B gene may be a susceptibility factor for with temporal lobe epilepsy (TLE) development. The rs6296 G allele has been associated with decreased receptor activity. Our aim was to analyse the association between rs6296 and the development and clinical features of Mesial Temporal Lobe Epilepsy (MTLE) in a Portuguese population. Material and methods: A cohort of 121 MTLE patients (67 F, 54 M, mean age = 44 ± 11 years, age of onset = 13 ± 9 years) was compared with a cohort of 192 healthy individuals (HI). All patients had Hippocampal Sclerosis (MTLE–HS). Genotyping was performed by TaqMan real time PCR methodology. Results: rs6296 G allele was overrepresented in MTLE patients compared to controls (80.2% in MTLE vs 72.1% in HI, p = 0.029 OR = 1.561 (1.060–2.298)). We constituted 2 MTLE–HS sub-groups, according to febrile seizure antecedents and no differences in rs6596 allelic or genotypic frequencies were found. Conclusion: The rs6296 G allele may be a susceptibility factor to MTLE–HS development. Since these receptors have an anticonvulsant role, a reduction in their activity could lower the threshold for seizure development.por
dc.description.sponsorshipSupported by a BICE Tecnifar Grant 2012por
dc.identifier.citationJ Neurol Sci. 2013;133(S1):e41por
dc.identifier.issn0022-510X
dc.identifier.urihttp://hdl.handle.net/10400.18/2216
dc.language.isoengpor
dc.peerreviewednopor
dc.publisherElsevier/ World Federation of Neurologypor
dc.relation.publisherversionhttp://www.sciencedirect.com/science/article/pii/S0022510X13004607
dc.subjectEpilepsypor
dc.subjectMTLEpor
dc.subjectSerotoninpor
dc.subjectHTR1Bpor
dc.subjectGenetic Associationpor
dc.subjectComplex Disease Geneticspor
dc.subjectDeterminantes da Saúde e da Doençapor
dc.subjectDoenças Genéticaspor
dc.titleIs serotonin receptor HTR1B implicated in mesial temporal lobe epilepsy development?por
dc.typeconference object
dspace.entity.typePublication
oaire.citation.conferencePlaceVienna, Austriapor
oaire.citation.endPagee41por
oaire.citation.startPagee41por
oaire.citation.titleXXI World Congress of Neurology, 21-26 September 2013por
oaire.citation.volume333(S1)por
rcaap.rightsembargoedAccesspor
rcaap.typeconferenceObjectpor

Files

Original bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
Leal2013-JNC.pdf
Size:
56.73 KB
Format:
Adobe Portable Document Format
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description: